Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial

Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial

Abstract Background The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and should be proposed in high-risk (HR) patients. However, the lack of accuracy in identifying HR patients with conventiona...

Full description

Bibliographic Details
Main Authors: Thomas Filleron, Sophie Le Guellec, Christine Chevreau, Bastien Cabarrou, Tom Lesluyes, Sabrina Lodin, Angélique Massoubre, Muriel Mounier, Muriel Poublanc, Frédéric Chibon, Thibaud Valentin
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cancer
Subjects:
Soft tissue sarcoma
CINSARC signature
Chemotherapy
Target selection design
Online Access:http://link.springer.com/article/10.1186/s12885-020-07207-3

Internet

http://link.springer.com/article/10.1186/s12885-020-07207-3

Similar Items